Francisco J. Toyos‐Sáenz de Miera

Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice

Monica Calderón-Goercke, J. Loricera, Vicente Aldasoro et al. · Seminars in Arthritis and Rheumatism · 2019 · 105 citations · Full text

Rheumatology, Autoimmune Disease, Vasculitis +6

Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases

Belén Atienza‐Mateo, J. L. Martín-Varillas, V. Calvo-Río et al. · Arthritis & Rheumatology · 2019 · 105 citations · Full text

Anti-IL-6 Receptor Tocilizumab in Refractory Graves’ Orbitopathy: National Multicenter Observational Study of 48 Patients

L. Sánchez-Bilbao, D. Martínez-López, Marcelino Revenga et al. · Journal of Clinical Medicine · 2020 · 81 citations · Full text

Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease

J. L. Martín-Varillas, V. Calvo-Río, E. Beltrán et al. · Ophthalmology · 2018 · 65 citations · Full text

Autoimmune Disease, Ophthalmology, Immunology +6

Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice.

Monica Calderón-Goercke, Santos Castañeda, Vicente Aldasoro et al. · PubMed · 2020 · 34 citations